Article: Osteologix Secures Positive JPO Patent Decision for Key Osteoporosis Drug

Article: Osteologix Gets Positive JPO Patent Decision for ...
Health & Beauty Close-Up;  August 25, 2009 ;     565 words ... ... cover the treatment of osteoporosis and related bone conditions using NB S101 (strontium malonate), the Company's lead osteoporosis drug candidate. The Company expects the patent will issue by the end of 2009. The patent's 20-year term will expire in ...

Article: Amgen near breakthrough on osteoporosis drug.
Denver Post (Denver, CO);  August 10, 2005 ;     700+ words ... ... testing of what could be a breakthrough osteoporosis drug that would be produced in Boulder ... in San Francisco. By 2006, the osteoporosis drug market will reach $11.5 billion ... prescribed Fosamax, the leading osteoporosis drug. (She is not a part of Amgen ...

Article: Pfizer helping state firm develop osteoporosis drug
The Milwaukee Journal Sentinel;  January 15, 2003 ;     700+ words ... ... Pfizer helping state firm develop osteoporosis drug By JASON GERTZEN jgertzen@journalsentinel ... biotechnology start-up to develop an osteoporosis drug received a $42.5 million boost ... and Pfizer are able to develop an osteoporosis drug that gains approval from federal ...

Article: OSTEOPOROSIS DRUG WORKS IN MEN, STUDY REVEALS ...
The Cincinnati Post (Cincinnati, OH);  September 1, 2000 ;     700+ words ... ... of Medicine, is the first large study of men given an osteoporosis drug. ''We perceive it as a women's disease and have totally ... for postmenopausal osteoporosis and is the top-selling osteoporosis drug. Fosamax and another drug, Actonel, are approved for ...

Article: Osteoporosis drug found to work in men
The Milwaukee Journal Sentinel;  August 31, 2000 ;     297 words ...Osteoporosis drug found to work in men, too From Journal Sentinel wire reports Thursday ... Journal of Medicine, is the first large study of men given an osteoporosis drug, in this case Fosamax, also known as alendronate. The study ...

Article: Osteoporosis drug prevents decline after hip ...
Post-Tribune (IN);  November 13, 2007 ;     473 words ... ... DIFFER SLIGHTLY FROM PRINTED VERSION After a hip break, an osteoporosis drug might help avoid more problems. The question For some ... surgery for a broken hip to receive a yearly injection of the osteoporosis drug zoledronic acid (Zometa) or a placebo. Everyone also ...

Article: Osteoporosis drug found to prevent breast cancer
Xinhua News Agency;  April 18, 2006 ;     437 words ...Osteoporosis drug found to prevent breast cancer WASHINGTON, April 18 (Xinhua) -- A U.S. study shows a widely-used osteoporosis drug Raloxifene can protect postmenopausal women from breast cancer as effectively as long-prescribed breast ...